Synthetic absorbable hemostatic agent

Details Synthetic absorbable hemostatic agent Synthetic absorbable hemostatic agent

1982-11-16

1984-04-17

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

528354, 528358, A61K 3174, C08G 6308

Patent

active

044434308

ABSTRACT:
A synthetic absorbable hemostatic agent for use in the control of osseous hemorrhage, comprising a copolymer of lactide and glycolide containing from about 30% to 70% lactide on a molar basis, and having a molecular weight such that it possesses a putty-like consistency at room temperature. The preferred agent has a lactide/glycolide molar ratio of 65:35 and a molecular weight of between 2000 and 2500 Dalton. The agent may also be mixed with a biocompatible base.

REFERENCES:
patent: 2668162 (1954-02-01), Lowe
patent: 2772999 (1956-12-01), Masci et al.
patent: 3395217 (1968-07-01), Statt
patent: 3636956 (1972-01-01), Schneider
patent: 4137921 (1979-02-01), Okuzumi et al.
patent: 4186448 (1980-02-01), Brekke
patent: 4201216 (1980-05-01), Mattei

Affiliated with

Also associated with

Rating

Synthetic absorbable hemostatic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic absorbable hemostatic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic absorbable hemostatic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-95126